Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 203

1.

Sympathetic nervous system: role in hypertension and in chronic kidney disease.

Grassi G, Bertoli S, Seravalle G.

Curr Opin Nephrol Hypertens. 2012 Jan;21(1):46-51. doi: 10.1097/MNH.0b013e32834db45d. Review.

PMID:
22080859
2.

Role of the sympathetic nervous system in hypertension and hypertension-related cardiovascular disease.

Seravalle G, Mancia G, Grassi G.

High Blood Press Cardiovasc Prev. 2014 Jun;21(2):89-105. doi: 10.1007/s40292-014-0056-1. Epub 2014 May 1. Review.

PMID:
24789091
3.

The sympathetic nervous system and new nonpharmacologic approaches to treating hypertension: a focus on renal denervation.

Grassi G, Seravalle G, Brambilla G, Mancia G.

Can J Cardiol. 2012 May;28(3):311-7. doi: 10.1016/j.cjca.2011.11.005. Epub 2012 Jan 14. Review.

PMID:
22244774
4.

The human sympathetic nervous system: its relevance in hypertension and heart failure.

Parati G, Esler M.

Eur Heart J. 2012 May;33(9):1058-66. doi: 10.1093/eurheartj/ehs041. Epub 2012 Apr 16. Review.

PMID:
22507981
5.

Renal and cardiac effects of renal sympathetic denervation and carotid baroreceptor stimulation.

Tsioufis C, Dimitriadis K, Thomopoulos C, Doumas M, Papademetriou V, Stefanadis C.

Curr Vasc Pharmacol. 2014 Jan;12(1):55-62. Review.

PMID:
23905593
6.

Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation.

Hering D, Esler MD, Schlaich MP.

EuroIntervention. 2013 May;9 Suppl R:R127-35. doi: 10.4244/EIJV9SRA22. Review.

PMID:
23732145
7.

The interplay between sympathetic overactivity, hypertension and heart rate variability (review, invited).

Drenjancevic I, Grizelj I, Harsanji-Drenjancevic I, Cavka A, Selthofer-Relatic K.

Acta Physiol Hung. 2014 Jun;101(2):129-42. doi: 10.1556/APhysiol.101.2014.2.1. Review.

PMID:
24901074
8.

Regulation of the sympathetic nervous system by the kidney.

Larsen R, Thorp A, Schlaich M.

Curr Opin Nephrol Hypertens. 2014 Jan;23(1):61-8. doi: 10.1097/01.mnh.0000437610.65287.db. Review.

PMID:
24275767
9.

Sympathetic activation in cardiovascular and renal disease.

Grassi G, Arenare F, Pieruzzi F, Brambilla G, Mancia G.

J Nephrol. 2009 Mar-Apr;22(2):190-5. Review.

PMID:
19384835
10.

Evidence for a critical role of the sympathetic nervous system in hypertension.

Grassi G, Ram VS.

J Am Soc Hypertens. 2016 May;10(5):457-66. doi: 10.1016/j.jash.2016.02.015. Epub 2016 Mar 4. Review.

PMID:
27052349
11.

The role of sympathetic nervous activity in renal injury and end-stage renal disease.

Masuo K, Lambert GW, Esler MD, Rakugi H, Ogihara T, Schlaich MP.

Hypertens Res. 2010 Jun;33(6):521-8. doi: 10.1038/hr.2010.35. Epub 2010 Mar 26. Review.

PMID:
20339374
12.

Renal denervation: current implications and future perspectives.

Xu J, Hering D, Sata Y, Walton A, Krum H, Esler MD, Schlaich MP.

Clin Sci (Lond). 2014 Jan 1;126(1):41-53. doi: 10.1042/CS20120581. Review.

PMID:
24020446
13.

Transcatheter renal artery sympathetic denervation for resistant hypertension: an old paradigm revisited.

Tam GM, Yan BP, Shetty SV, Lam YY.

Int J Cardiol. 2013 Apr 15;164(3):277-81. doi: 10.1016/j.ijcard.2012.01.048. Epub 2012 Feb 14. Review.

PMID:
22336259
14.

Sympathetic overdrive and cardiovascular risk in the metabolic syndrome.

Grassi G.

Hypertens Res. 2006 Nov;29(11):839-47. Review.

PMID:
17345783
15.

Similarities and differences between renal sympathetic denervation and carotid baroreceptor stimulation.

Grassi G, Seravalle G, Brambilla G, Cesana F, Giannattasio C, Mancia G.

Curr Vasc Pharmacol. 2014 Jan;12(1):63-8. Review.

PMID:
23905595
16.

The sympathetic nervous system alterations in human hypertension.

Grassi G, Mark A, Esler M.

Circ Res. 2015 Mar 13;116(6):976-90. doi: 10.1161/CIRCRESAHA.116.303604. Review.

17.

The 'neuroadrenergic hypothesis' in hypertension: current evidence.

Grassi G, Seravalle G, Quarti-Trevano F.

Exp Physiol. 2010 May;95(5):581-6. doi: 10.1113/expphysiol.2009.047381. Epub 2009 Dec 11. Review.

18.

Mediators of target organ damage in hypertension: focus on obesity associated factors and inflammation.

Dawood T, Schlaich MP.

Minerva Cardioangiol. 2009 Dec;57(6):687-704. Review.

PMID:
19942842
19.

Electrical carotid sinus stimulation in treatment resistant arterial hypertension.

Jordan J, Heusser K, Brinkmann J, Tank J.

Auton Neurosci. 2012 Dec 24;172(1-2):31-6. doi: 10.1016/j.autneu.2012.10.009. Epub 2012 Nov 9. Review.

PMID:
23146623
20.

Pathogenesis of hypertension in renal failure: role of the sympathetic nervous system and renal afferents.

Phillips JK.

Clin Exp Pharmacol Physiol. 2005 May-Jun;32(5-6):415-8. Review.

PMID:
15854151

Supplemental Content

Support Center